Results 81 to 90 of about 405 (90)
TAC1b mutation in Candida auris decreases manogepix susceptibility owing to increased CDR1 expression. [PDF]
Candida auris is an emerging pathogenic fungus that is highly resistant to existing antifungal drugs. Manogepix is a novel antifungal agent that exerts antifungal activity by inhibiting glycosylphosphatidylinositol anchor biosynthesis.
Masato Tashiro +2 more
exaly +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Enhanced Efflux Pump Expression in Candida Mutants Results in Decreased Manogepix Susceptibility.
Antimicrobial Agents and Chemotherapy, 2020Leah E Cowen +2 more
exaly
Synthesis of analogs of the Gwt1 inhibitor manogepix (APX001A) and evaluation against spp
Bioorganic and Medicinal Chemistry Letters, 2019Karen J Shaw, Mili Kapoor
exaly
Evaluation of Resistance Development to the Gwt1 Inhibitor Manogepix (APX001A) in Candida Species.
Antimicrobial Agents and Chemotherapy, 2019Karen J Shaw, Mili Kapoor
exaly

